Sheila Denton
Vermogen: 3 M $ op 31-05-2026
Vermogen: 3 M $ op 31-05-2026
Sheila A. Denton worked at Boehringer Ingelheim USA, Inc. as Secretary, Senior Vice President & General Counsel.
From 2023 to 2025, served at Incyte Corp.
as Secretary, Executive VP & General Counsel.
Education includes undergraduate studies at the University of the Sacred Heart and graduate studies at Western New England University School of Law.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
INCYTE CORPORATION 0,01% | 17-11-2025 | 26.569 ( 0,01% ) | 3 M $ | 31-05-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| INCYTE CORPORATION | Algemeen Adviseur | 01-12-2025 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Incyte Corp.
Incyte Corp. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of proprietary therapeutics | Health Technology |
University of the Sacred Heart
University of the Sacred Heart Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Western New England University School of Law
Western New England University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kies jouw editie
Alle financiële informatie op nationaal niveau